TG Therapeutics Inc (NASDAQ:TGTX) price on Friday, April 19, fall -1.72% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $13.75.
A look at the stock’s price movement, the level at last check in today’s session was $13.99. The beta value (5-Year monthly) was 2.32 while the PE ratio in trailing twelve months stood at 975.18. Turning to its 52-week performance, $35.67 and $6.46 were the 52-week high and 52-week low respectively. Overall, TGTX moved -10.54% over the past month.
TG Therapeutics Inc’s market cap currently stands at around $2.12 billion, with investors looking forward to this quarter’s earnings report slated for Apr 29, 2024 – May 03, 2024.
Revisions could be used as tool to get short term price movement insight, and for the company that in the past seven days was no upward and no downward review(s). Turning to the stock’s technical picture we see that short term indicators suggest on average that TGTX is a 50% Sell. On the other hand, the stock is on average a Hold as suggested by medium term indicators while long term indicators are putting the stock in Hold category.
TGTX’s current price about -6.74% and -9.12% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 35.15, while 7-day volatility ratio is 4.87% and 4.00% in the 30-day chart. Further, TG Therapeutics Inc (TGTX) has a beta value of 2.31, and an average true range (ATR) of 0.66.
If we refocus on TG Therapeutics Inc (NASDAQ:TGTX), historical trading data shows that trading volumes averaged 3.54 million over the past 3 months. The company’s latest data on shares outstanding shows there are 151.42 million shares.
The 9.56% of TG Therapeutics Inc’s shares are in the hands of company insiders while institutional holders own 58.81% of the company’s shares. Current price change has pushed the stock -19.50% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the TGTX stock continues to rise going into the next quarter.
